- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
US Dept of Justice to Arraign PharmacyChecker Exec on Counterfeit and Mislabeled Drugs Charges
August 18, 2015.
In a U.S. Department of Justice (DOJ) indictment handed down by a grand jury in November 2014 and unsealed on August 11, 2015, the Director of Pharmacy Policy and International Verifications for New York-based PharmacyChecker.com, Ram Kamath, PharmD, and Winnipeg-based CanadaDrugs.com are among fourteen individuals and companies charged with crimes related to the sale of $78 million worth of mislabeled and counterfeit prescription drugs, including smuggling, improper storage, falsifying customs declarations, money laundering and conspiracy.
Kamath will be arraigned in a U.S. federal court on Tuesday, August 25. The other defendants, located outside the U.S., have not yet been extradited to face the charges.
Source: PR Newswire
